202 related articles for article (PubMed ID: 22045403)
1. Prognostic assessment in patients with hepatic encephalopathy.
García-Martínez R; Simón-Talero M; Córdoba J
Dis Markers; 2011; 31(3):171-9. PubMed ID: 22045403
[TBL] [Abstract][Full Text] [Related]
2. Classification of cirrhosis: the clinical use of HVPG measurements.
Albilllos A; Garcia-Tsao G
Dis Markers; 2011; 31(3):121-8. PubMed ID: 22045397
[TBL] [Abstract][Full Text] [Related]
3. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic markers in liver cirrhosis.
Augustin S; Genescà J
Dis Markers; 2011; 31(3):119-20. PubMed ID: 22045396
[No Abstract] [Full Text] [Related]
5. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
[TBL] [Abstract][Full Text] [Related]
7. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
[TBL] [Abstract][Full Text] [Related]
8. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
D'Amico G; Morabito A; D'Amico M; Pasta L; Malizia G; Rebora P; Valsecchi MG
Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
[TBL] [Abstract][Full Text] [Related]
10. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
[TBL] [Abstract][Full Text] [Related]
11. Prognostic markers in patients with ascites and hepatorenal syndrome.
Nazal L; Cárdenas A
Dis Markers; 2011; 31(3):139-46. PubMed ID: 22045399
[No Abstract] [Full Text] [Related]
12. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
[TBL] [Abstract][Full Text] [Related]
13. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
Deng D; Liao MS; Qin JP; Li XA
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
[TBL] [Abstract][Full Text] [Related]
14. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
15. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
16. TIPS for management of refractory ascites: response and survival are both unpredictable.
Thuluvath PJ; Bal JS; Mitchell S; Lund G; Venbrux A
Dig Dis Sci; 2003 Mar; 48(3):542-50. PubMed ID: 12757168
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in children.
Di Giorgio A; Agazzi R; Alberti D; Colledan M; D'Antiga L
J Pediatr Gastroenterol Nutr; 2012 May; 54(5):594-600. PubMed ID: 22228077
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.
Zipprich A; Garcia-Tsao G; Rogowski S; Fleig WE; Seufferlein T; Dollinger MM
Liver Int; 2012 Oct; 32(9):1407-14. PubMed ID: 22679906
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care.
Bohra A; Worland T; Hui S; Terbah R; Farrell A; Robertson M
World J Gastroenterol; 2020 May; 26(18):2221-2231. PubMed ID: 32476788
[TBL] [Abstract][Full Text] [Related]
20. Prognostic markers in patients with cirrhosis and portal hypertension who have not bled.
Poca M; Puente A; Graupera I; Villanueva C
Dis Markers; 2011; 31(3):147-54. PubMed ID: 22045400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
